{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:25:18Z","timestamp":1792297518225,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CA099936"],"award-info":[{"award-number":["CA099936"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RP-17-216-06-COUN"],"award-info":[{"award-number":["RP-17-216-06-COUN"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children's Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA099936"],"award-info":[{"award-number":["CA099936"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA276480"],"award-info":[{"award-number":["CA276480"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA154998"],"award-info":[{"award-number":["CA154998"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA151845"],"award-info":[{"award-number":["CA151845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA228760"],"award-info":[{"award-number":["CA228760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.omton.2024.200783","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T12:37:26Z","timestamp":1709123846000},"page":"200783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-1452","authenticated-orcid":false,"given":"Julia A.","family":"Nikrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Galvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie M.","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan L.","family":"Novacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas M.A.S.","family":"Corbi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline J.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler A.","family":"Jubenville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2024.200783_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/PAS.0000000000000655","article-title":"Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients from the French Sarcoma Group Database","volume":"40","author":"Le Guellec","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.omton.2024.200783_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13311-017-0518-y","article-title":"Cancer of the Peripheral Nerve in Neurofibromatosis Type 1","volume":"14","author":"Staedtke","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omton.2024.200783_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1158\/1541-7786.MCR-19-0147","article-title":"Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside","volume":"17","author":"Korfhage","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2024.200783_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.20601","article-title":"Germline and Somatic NF1 Gene Mutation Spectrum in NF1-Associated Malignant Peripheral Nerve Sheath Tumors (MPNSTs)","volume":"29","author":"Upadhyaya","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omton.2024.200783_bib5","first-page":"i50","article-title":"Genetics of Human Malignant Peripheral Nerve Sheath Tumors","volume":"2","author":"Pemov","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.omton.2024.200783_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant Peripheral Nerve Sheath Tumours in Neurofibromatosis","volume":"39","author":"Evans","year":"2002","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omton.2024.200783_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/B978-0-444-52902-2.00053-9","article-title":"Neurofibromatosis Type 1 (NF1): Diagnosis and Management. Vol 115","volume":"115","author":"Ferner","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.omton.2024.200783_bib8","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41388-022-02290-1","article-title":"Malignant Peripheral Nerve Sheath Tumor: Models, Biology, and Translation","volume":"41","author":"Somatilaka","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200783_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(98)00223-5","article-title":"Malignant Peripheral Nerve Sheath Tumor: Analysis of Treatment Outcome","volume":"42","author":"Wong","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.omton.2024.200783_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant Peripheral Nerve Sheath Tumors: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2024.200783_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1750-1172-8-127","article-title":"Chemotherapy for the Treatment of Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis 1: A 10-year Institutional Review","volume":"8","author":"Zehou","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omton.2024.200783_bib12","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1200\/JCO.2005.01.4886","article-title":"Pediatric Malignant Peripheral Nerve Sheath Tumor: The Italian and German Soft Tissue Sarcoma Cooperative Group","volume":"23","author":"Carli","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200783_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2015.12.015","article-title":"Management and Prognosis of Malignant Peripheral Nerve Sheath Tumors: The Experience of the French Sarcoma Group (GSF-GETO)","volume":"56","author":"Valentin","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omton.2024.200783_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/v8020043","article-title":"To Infection and Beyond: The Multi-pronged Anti-cancer Mechanisms of Oncolytic Viruses","volume":"8","author":"Cassady","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2024.200783_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/1097-0142(194905)2:3<516::AID-CNCR2820020316>3.0.CO;2-P","article-title":"Effect of Inoculation of the Viruses of Influenza A and Herpes Simplex on the Growth of Transplantable Tumors in Mice","volume":"2","author":"Moore","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/j.omton.2024.200783_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic Virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2024.200783_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40425-018-0458-z","article-title":"Oncolytic Virus Immunotherapy: Future Prospects for Oncology","volume":"6","author":"Raja","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omton.2024.200783_bib18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","article-title":"Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy","volume":"170","author":"Ribas","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200783_bib19","doi-asserted-by":"crossref","first-page":"FNL7","DOI":"10.2217\/fnl-2018-0026","article-title":"Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumors","volume":"14","author":"Wu","year":"2019","journal-title":"Future Neurol."},{"key":"10.1016\/j.omton.2024.200783_bib20","doi-asserted-by":"crossref","first-page":"64300","DOI":"10.18632\/oncotarget.11734","article-title":"Characterizing the Immune Microenvironment of Malignant Peripheral Nerve Sheath Tumor by PD-L1 Expression and Presence of CD8+ Tumor Infiltrating Lymphocytes","volume":"7","author":"Shurell","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200783_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2005.12.027","article-title":"Immune System Evasion by Peripheral Nerve Sheath Tumor","volume":"397","author":"Lee","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omton.2024.200783_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12865-022-00522-3","article-title":"The immune subtypes and landscape of sarcomas","volume":"23","author":"Weng","year":"2022","journal-title":"BMC Immunol."},{"key":"10.1016\/j.omton.2024.200783_bib23","doi-asserted-by":"crossref","first-page":"e153437","DOI":"10.1172\/JCI153437","article-title":"Tumor-intrinsic PRC2 Inactivation Drives a Context-dependent Immune-desert Microenvironment and is Sensitized by Immunogenic Viruses","volume":"132","author":"Yan","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omton.2024.200783_bib24","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: An update","volume":"20","author":"Ginn","year":"2018","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omton.2024.200783_bib25","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.3390\/ijms221910522","article-title":"Concepts in Oncolytic Adenovirus Therapy","volume":"22","author":"Mantwill","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200783_bib26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/sj.gt.3301747","article-title":"Transcriptional Targeting Of Conditionally Replicating Adenovirus to Dividing Endothelial Cells","volume":"9","author":"Savontaus","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2024.200783_bib27","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/1078-0432.CCR-06-2103","article-title":"E1A, E1B Double-restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR-deficient Biliary Cancers","volume":"13","author":"Wakayama","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200783_bib28","first-page":"571","article-title":"Oncolytic Viruses\u00a0& Their Specific Targeting to Tumour Cells","volume":"136","author":"Singh","year":"2012","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.omton.2024.200783_bib29","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1038\/sj.onc.1204094","article-title":"Replication-selective Oncolytic Adenoviruses: Virotherapy Aimed at Genetic Targets in Cancer","volume":"19","author":"Kirn","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200783_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/cancers10060201","article-title":"Designer Oncolytic Adenovirus: Coming of Age","volume":"10","author":"Baker","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200783_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157488509788185123","article-title":"Adenoviral Vector-based Strategies for Cancer Therapy","volume":"4","author":"Sharma","year":"2009","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.omton.2024.200783_bib32","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","article-title":"Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 Fibritin","volume":"75","author":"Krasnykh","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200783_bib33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1126\/science.286.5444.1568","article-title":"Identification of a Conserved Receptor-Binding Site on the Fiber Proteins of CAR-Recognizing Adenoviridae","volume":"286","author":"Roelvink","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.omton.2024.200783_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1568009617666170222123925","article-title":"The development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer","volume":"18","author":"Sato-Dahlman","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.omton.2024.200783_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/cancers11020198","article-title":"Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5\/3 Oncolytic Adenoviruses","volume":"11","author":"Koodie","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200783_bib36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omton.2024.200783_bib37","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omton.2024.200783_bib38","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200783_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a Receptor for Adenovirus Serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2024.200783_bib40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.gt.3301898","article-title":"Conditionally Replicating Viruses in Cancer Therapy","volume":"10","author":"Connolly","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omton.2024.200783_bib41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1470-2045(00)00030-9","article-title":"Conditionally Replicative Adenoviral Vectors for Cancer Gene Therapy","volume":"1","author":"G\u00f3mez-Navarro","year":"2000","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omton.2024.200783_bib42","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1158\/0008-5472.CAN-04-0064","article-title":"Infectivity-enhanced Cyclooxygenase-2-based Conditionally Replicative Adenoviruses for Esophageal Adenocarcinoma Treatment","volume":"64","author":"Davydova","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200783_bib43","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and Regulation of Cyclooxygenase-2 During Inflammation","volume":"106","author":"Simon","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.omton.2024.200783_bib44","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in Cancer: A Review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omton.2024.200783_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088035","article-title":"Overexpression of Cyclooxygenase-2 In Malignant Peripheral Nerve Sheath Tumor and Selective Cyclooxygenase-2 Inhibitor-induced Apoptosis by Activating Caspases in Human Malignant Peripheral Nerve Sheath Tumor Cells","volume":"9","author":"Hakozaki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200783_bib46","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/genes11070762","article-title":"Preventative effect of mebendazole against malignancies in neurofibromatosis 1","volume":"11","author":"Staedtke","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.omton.2024.200783_bib47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/cancers12051295","article-title":"Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination","volume":"12","author":"Sato-Dahlman","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200783_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/21678707.2016.1128322","article-title":"Prospect and Progress of Oncolytic Viruses for Treating Peripheral Nerve Sheath Tumors","volume":"4","author":"Antoszczyk","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omton.2024.200783_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40425-019-0623-z","article-title":"Final analyses of OPTiM: a Randomized Phase III trial of Talimogene Laherparepvec Versus Granulocyte-macrophage Colony-Stimulating Factor in Unresectable Stage III\u2013IV Melanoma","volume":"7","author":"Andtbacka","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omton.2024.200783_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0168-1702(89)90026-9","article-title":"Restricted Replication of Human Adenovirus Type 5 in Mouse Cell Lines","volume":"14","author":"Blair","year":"1989","journal-title":"Virus Res."},{"key":"10.1016\/j.omton.2024.200783_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200783_bib52","first-page":"vdab129","article-title":"A Genetic Mouse Model with Postnatal Nf1 and p53 Loss recapitulates the Histology and Transcriptome of Human Malignant Peripheral Nerve Sheath Tumor","volume":"3","author":"Inoue","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.omton.2024.200783_bib60","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/0008-5472.CAN-05-3330","article-title":"Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues","volume":"66","author":"Miller","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200783_bib53","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1158\/1078-0432.CCR-14-3049","article-title":"Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma","volume":"21","author":"Hirbe","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200783_bib54","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.3390\/cancers15225455","article-title":"Revealing Pan-histology Immunomodulatory Targets in Pediatric Central Nervous System Tumors","volume":"15","author":"Galvin","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200783_bib55","article-title":"Oncolytic Adenovirus: Prospects for Cancer Immunotherapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omton.2024.200783_bib56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00428-009-0848-1","article-title":"Establishment and Characterization of a Novel Human Malignant Peripheral Nerve Sheath Tumor Cell Line, FMS-1, that Overexpresses Epidermal Growth Factor Receptor and Cyclooxygenase-2","volume":"455","author":"Hakozaki","year":"2009","journal-title":"Virchows Arch."},{"key":"10.1016\/j.omton.2024.200783_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S1740925X04000262","article-title":"Prostaglandin E2 Metabolism is Activated In Schwann Cell Lines Derived From Human Nf1 Malignant Peripheral Nerve Sheath Tumors","volume":"1","author":"Deadwyler","year":"2004","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.omton.2024.200783_bib58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of Subcutaneous Tumor Size in Athymic (Nude) Mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.omton.2024.200783_bib59","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved Predictions of MHC Antigen Presentation by Concurrent Motif Deconvolution and Integration of MS MHC Eluted Ligand Data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2024.200783_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data reposotory","volume":"30","author":"Eddgar","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:19:37Z","timestamp":1765804777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329924000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2950329924000250"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2024.200783","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2024.200783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"200783"}}